Shenzhen Neptunus Interlong Bio-Technique Co Ltd
08329
Company Profile
Business description
Shenzhen Neptunus Interlong Bio-Technique Co Ltd is engaged in the research and development, manufacturing, and selling of medicines and medical devices. It is also involved in the purchase and sales of medicines and healthcare food products. The group's revenue and results from operations are mainly derived from activities in the PRC. The operating segments of the company are the Manufacturing and selling of medicines; and the Sales and distribution of medicines and healthcare products. The majority of revenue is generated from the Manufacturing and selling of medicines.
Contact
95 Queensway
18th Floor, United Centre
Admiralty
Hong Kong
HKGSector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
1,471
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,366.60 | 481.00 | -6.13% |
| CAC 40 | 7,274.95 | 324.03 | -4.26% |
| DAX 40 | 20,641.72 | 1,075.67 | -4.95% |
| Dow JONES (US) | 38,445.03 | 2,100.90 | -5.18% |
| FTSE 100 | 8,054.98 | 419.76 | -4.95% |
| HKSE | 22,849.81 | 352.72 | -1.52% |
| NASDAQ | 15,604.17 | 946.44 | -5.72% |
| Nikkei 225 | 31,459.76 | 2,320.82 | -6.87% |
| NZX 50 Index | 11,780.35 | 444.93 | -3.64% |
| S&P 500 | 5,084.85 | 311.67 | -5.78% |
| S&P/ASX 200 | 7,193.10 | 474.70 | -6.19% |
| SSE Composite Index | 3,342.01 | 0.00 | 0.00% |